Stolf, Anderson R.
Cupertino, Renata B.
Müller, Diana
Sanvicente-Vieira, Breno
Roman, Tatiana
Vitola, Eduardo S.
Grevet, Eugenio H.
von Diemen, Lisia
Kessler, Felix H. P.
Grassi-Oliveira, Rodrigo
Bau, Claiton H. D.
Rovaris, Diego L.
Pechansky, Flavio
Schuch, Jaqueline B. http://orcid.org/0000-0002-2195-4407
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (476529/2012-3, 466722/2014-1, 466802/2014-5)
Secretaria Nacional de Políticas sobre Drogas (82264/2015)
Article History
Received: 20 April 2018
Accepted: 17 October 2018
First Online: 26 October 2018
Compliance with ethical standards
:
: The author(s) declare the following potential conflict of interest with respect to the research, authorship, and/or publication of this article: Dr. Grevet was on the speaker’s bureau for Novartis and Shire for the last 3 years. He also received travel awards (air tickets and hotel accommodations) for participating in two psychiatric meetings from Shire and Novartis. All other authors reported no financial interests or potential conflicts of interest.